OSR Health (OSRHW) Cash from Operations Growth (3y) (2025 - 2026)

OSR Health (OSRHW) Cash from Operations Growth (3y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Ops. Growth (3y) (Qtr)
1	Vertex Pharmaceuticals	138.97 Bn	131.12 Bn	2.84 Bn	-0.27%
2	Regeneron Pharmaceuticals	85.15 Bn	77.15 Bn	3.93 Bn	-7.35%
3	Argenx Se	62.84 Bn	57.65 Bn	1.37 Bn	-
4	Moderna	55.74 Bn	50.60 Bn	52.00 Mn	16.85%
5	BeOne Medicines	41.53 Bn	36.43 Bn	1.53 Bn	52.90%
6	Alnylam Pharmaceuticals	31.60 Bn	28.29 Bn	992.69 Mn	96.08%
7	BioNTech SE	27.32 Bn	8.93 Bn	668.28 Mn	-24.76%
8	Royalty Pharma	27.29 Bn	26.45 Bn	-	6.22%
9	Insmed	26.99 Bn	25.83 Bn	358.27 Mn	10.23%
10	OSR Health	1.40 Mn	20.39 Mn	86,605.00	-90.96%

Download Data